Dr.  Amir Sonnenblick

​Oncology, Breast Cancer

​2013-2015- ESMO Breast Cancer Translational and Clinical Research Fellowship, Jules Bordet Institute, Brussels.

2012- Fellowship in Breast Cancer Research, International Program at Emory University, Atlanta, GA, USA. 

​2018-Present - Head, Breast Cancer Unit, 

The Oncology Division, Tel Aviv Sourasky Medical Center, Tel Aviv.

2013-2018- Senior Physician, Oncology Department, Hadassah Medical Center, Jerusalem.

2013-2015- Medical Advisor for the Breast European Adjuvant Studies Team and the Breast International Group (BIG). "Aphinity" and "Olympia" phase III trials.

2008-2012- Residency, Oncology Department, Hadassah Medical Center, Jerusalem.

2017-2018- Member of the Institutional Helsinki Committee –Hadassah Medical Center, Jerusalem.

2016-2018- Medical Oncology Course Coordinator. Faculty of Medicine Hebrew University, Jerusalem.

2016-present- Member of the Oncology Board Examinations Committee (writing questions for "stage 1" and examiner in "stage 2").

2015-2018- Member of the Examinations (OSCE) Committee Hebrew University, Jerusalem.

2015-2018- Member of the Admission Committee Hebrew University, Jerusalem.

2018- Present - Senior lecturer at the Faculty of Medicine Hebrew University, Jerusalem.

2014-2018- Lecturer at the Faculty of Medicine Hebrew University, Jerusalem.

​Over 30 presentations in national and international scientific meetings.

​For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

​

Grants

Israel Cancer Research Fund (ICRF)

Israel Cancer Association (ICA)

Kamin- Ministry of health

Awards

2004     Wolf Award for PhD students.

2006      Foulkes Award for MD/PhD students.

2013      ESMO Breast Cancer Translational Research Award.

2016       ISCORT Best Paper of the Year Award.

2017        ISCORT Best Paper of the Year Award.

​Member of the Israeli Medical Association, Israeli Society of Clinical Oncology, Israeli Society for Cancer Research (ISCR), European Association of Cancer Research (ESCR) and European Society of Medical Oncology (ESMO).

​Breast cancer, clinical and translational research, personalized medicine, cancer science teaching